Your browser doesn't support javascript.
loading
Safety and immunogenicity of a recombinant receptor-binding domain-based protein subunit vaccine (Noora vaccine™) against COVID-19 in adults: A randomized, double-blind, placebo-controlled, Phase 1 trial.
Salimian, Jafar; Ahmadi, Ali; Amani, Jafar; Olad, Gholamreza; Halabian, Raheleh; Saffaei, Ali; Arabfard, Masoud; Nasiri, Mojtaba; Nazarian, Shahram; Abolghasemi, Hassan; Alishiri, Gholamhossein.
Afiliación
  • Salimian J; Applied Microbiology Research Center, Systems Biology and Poisonings Institute, Baqiyatallah University of Medical Sciences, Tehran, Iran.
  • Ahmadi A; Chemical Injuries Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran.
  • Amani J; Molecular Biology Research Center, Systems Biology and Poisonings Institute, Baqiyatallah University of Medical Sciences, Tehran, Iran.
  • Olad G; Applied Microbiology Research Center, Systems Biology and Poisonings Institute, Baqiyatallah University of Medical Sciences, Tehran, Iran.
  • Halabian R; Applied Biotechnology Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran.
  • Saffaei A; Applied Microbiology Research Center, Systems Biology and Poisonings Institute, Baqiyatallah University of Medical Sciences, Tehran, Iran.
  • Arabfard M; Department of Clinical Pharmacy, School of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Nasiri M; ​Student Research Committee, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Nazarian S; Skull Base Research Center, Loghman Hakim Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Abolghasemi H; Chemical Injuries Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran.
  • Alishiri G; Clinical Trial Center, Tehran University of Medical Sciences, Tehran, Iran.
J Med Virol ; 95(2)2023 Feb.
Article en En | MEDLINE | ID: mdl-36029105

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: COVID-19 Tipo de estudio: Clinical_trials Límite: Adult / Humans Idioma: En Revista: J Med Virol Año: 2023 Tipo del documento: Article País de afiliación: Irán

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: COVID-19 Tipo de estudio: Clinical_trials Límite: Adult / Humans Idioma: En Revista: J Med Virol Año: 2023 Tipo del documento: Article País de afiliación: Irán